A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Healthy Participants

NCT05959109 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Peresolimab

Sponsor

Eli Lilly and Company